Samuel Eziokwu A, Varella L, Lynn Kruse M, Jia X, et al. Real-world Outcomes of Cyclin-dependent Kinase Inhibitors Continued Beyond First Disease Progression in Hormone Receptor-positive Metastatic Breast Cancer. Clin Breast Cancer 2020 Oct 2. pii: S1526-8209(20)30254.
PMID: 33189562